Trials / Withdrawn
WithdrawnNCT04652050
Evaluation of Tolsura When Used as Prophylaxis After Lung Transplantation
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Hong Nguyen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-center, observational study of Tolsura PK sampling in lung transplant recipients
Detailed description
Patients who are receiving Tolsura as part of their clinical care will be asked to enroll and EMR data and excess biological samples will be collected
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tolsura | Patients fulfilling the inclusion criteria (see above) and placed on Tolsura for prophylaxis, and signed informed consent to participate in this study will be part of the study. |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2023-04-01
- Completion
- 2023-04-01
- First posted
- 2020-12-03
- Last updated
- 2023-04-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04652050. Inclusion in this directory is not an endorsement.